In the title compound, 0.75C 12 H 14 ClNO 2 Á0.25C 12 H 14 ClNO, which is an adduct comprising 0.75 4-hydroxypiperidin-1-yl or 0.25 4-piperidin-1-yl substituents on a common (4-chlorophenyl)methanone component; the dihedral angles between the benzene ring and the two piperidine rings are 51.6 (3) and 89.5 (7)
Related literature
For the synthesis, see: Revathi et al. (2015) . For the biological activity of piperidine derivatives, see: Ramalingan et al. (2004) ; Sargent & May (1970) ; Rubiralta et al. (1991) . For related structures, see: Revathi et al. (2015) ; Prathebha et al. (2015) . Table 1 Hydrogen-bond geometry (Å , ).
Symmetry code: (i) x; y; z À 1.
Data collection: APEX2 (Bruker, 2004 ); cell refinement: APEX2 and SAINT (Bruker, 2004) ; data reduction: SAINT and XPREP (Bruker, 2004 ); program(s) used to solve structure: SIR92 (Altomare et al., 1993) ; program(s) used to refine structure: SHELXL2014 (Sheldrick, 2015) ; molecular graphics: ORTEP-3 for Windows (Farrugia, 2012) and Mercury (Bruno et al., 2002) ; software used to prepare material for publication: SHELXL2014.
been targeted for their total or partial synthesis (Ramalingan et al., 2004) . Piperidines are known to have CNS depressant action at low dosage levels and stimulant activity with increased dosages. In addition, the nucleus also possesses analgesic, ganglionic blocking and anesthetic properties as well (Sargent & May, 1970; Rubiralta et al., 1991) .
In the title compound In the crystal, molecules are linked by O2-H···O1 i hydrogen bonds (Table 1) , forming one-dimensional chains extending along c (Fig. 3 ). Present also are very weak inter-chain C12′-H···Cl1 ii interactions [3.63 (2) Å]. For symmetry code (ii) -x + 3/2, -y + 1, z -1.
S2. Experimental
The title compound was synthesized by utilizing a reported procedure . In a 250 ml round-bottomed flask, 130 ml of ethylmethylketone was added to 4-hydroxypiperidiene (0.04 mol) and stirred well. Triethylamine (0.04 mol) was then added and the mixture was stirred for 10 min. 4-Chlorobenzoyl chloride (0.04 mol) was added and the reaction mixture was stirred at room temperature for about 2 hr. A white precipitate of triethylammonium chloride was produced, which was filtered and the filtrate was evaporated to obtain the crude product, crystallization from ethylmethylketone gave colourless block-like crystals of the unexpected title adduct (yield: 88%).
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S3. Refinement
H atoms were positioned geometrically and treated as riding on their parent atoms and refined with, C-H distances of 0.93-0.98 Å, an O-H distance of 0.82 Å, with U iso (H)= 1.5 U eq (C-methyl), U iso (H)= 1.2U eq (C,O) for other H atoms. The value of the absolute structure parameter (Parsons et al., 2013) , although of no relevance for the present structure was determined as 0.03 (3) using 583 quotients [(I+)-(I-)]/[(I+)+(I-)].
Figure 1
The molecular structure of the major (73%) 4-hydroxypiperidin-1-yl substituted component of the title adduct, showing atom numbering, with displacement ellipsoids drawn at the 30% probability level.
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Fractional atomic coordinates and isotropic or equivalent isotropic displacement parameters (

